US FDA accredits GS1, HIBCC for issuing device identifiers as UDI rule architect departs
This article was originally published in SRA
The US Food and Drug Administration has accredited two global standards organizations, GS1 and the Health Industry Business Communications Council (HIBCC), for issuing unique device identifiers to support the implementation of the agency's new UDI regulations1,2. Separately, Jay Crowley, who was instrumental in authoring the FDA's UDI rule, is leaving the agency to join private consultancy firm USDM Life Sciences3.
You may also be interested in...
US FDA lays out for manufacturers how they should cobble together Unique Device Identifiers in a 10-page July 25 draft guidance. The document is intended to be a handy manual for firms as they work to meet UDI requirements and deadlines set by the agency.
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.
EU drug industry federation, EFPIA, is concerned that an increase in protectionist trade measures by some countries could result in tit-for-tat policies that could hamper the global response to contain COVID-19.